Project Grant K23DC022677

Award Date 5/1/25
Completion Date 4/30/30
Dollars Obligated $142K
Federal Grant Program
93.173
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $633,694 Project Grant (CFDA 93.173: Research Related to Deafness and Communication Disorders) to North Carolina State University (NC State) to develop a non-invasive therapy using a vocal fold lamina propria extract (VFLPX) to promote wound healing and reduce fibrotic scarring for vocal fold injuries and laryngotracheal conditions. The key objectives of the 5-year project are to: 1) conduct advanced proteomic...
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), aims to develop a novel biomarker for quantifying vocal hyperfunction, a common symptom of various voice disorders. The $1,375,744 award to New York University School of Medicine will fund research to create a spectrotemporal synergistic scan using synchronized multi-sensor surface...
The federal Project Grant award R01DC021425 for $653,547.00 was provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The grant aims to elucidate the immune dysregulation mechanisms underlying persistent post-COVID-19 olfactory dysfunction. Key objectives include defining the phenotype of infiltrating immune cells, determining how immune mediators disrupt olfactory stem...
This $564,134 Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) supports research by Harvard Medical School to investigate the relationship between experience-dependent transcriptional adaptation and olfactory function in the sensory system. The key objectives of the research project are to: 1) characterize how sensory neuron-specific gene expression...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will provide $415,743 to Oregon Health & Science University (OHSU) from February 1, 2025 through January 31, 2030 to investigate the origins and roles of macrophages in the development, homeostasis, and repair of the tympanic membrane (eardrum). The research project aims to use advanced techniques...
This $434,411 Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will support research at Brandeis University to investigate the mechanisms regulating the regeneration of chemosensory neuron cilia. The project aims to characterize the contribution of molecules involved in axon regeneration to cilia regrowth, as well as identify additional sensors,...
The National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders Federal Grant Program (CFDA 93.173), awarded a $450,000 Project Grant to Baylor University to investigate the impact of omega-3 polyunsaturated fatty acid (PUFA) supplementation on vocal fold inflammation and recovery in female professional voice users. The research aims to determine the feasibility and effects of omega-3 PUFA supplementation versus a...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders federal grant program (CFDA 93.173), is funding the development of an image-guided automated ultrafast laser device for laryngeal (voice box) surgery. The $277,810 award to Femtovox Incorporated will be used to demonstrate the superior performance of ultrafast lasers in minimizing collateral damage to laryngeal tissue,...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders Federal Grant Program (CFDA 93.173), provides $631,703 to The Washington University in St. Louis to investigate the use of muscle progenitor cells for treating vocal fold paralysis. The project aims to repeat preliminary findings demonstrating that implanting muscle progenitor cells into denervated laryngeal muscles can...
This $144,328 federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), supports patient-oriented research on communication and swallowing disorders in head and neck cancer (HNC) survivors. The key objectives are: 1) a randomized controlled trial to assess an intervention to increase participation in ototoxicity monitoring in HNC patients, and 2)...

This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), is focused on understanding the inflammatory mechanisms and immune responses underlying the development of glottic scarring following acute laryngeal injury. The $142,074 award to the University of Wisconsin-Madison will employ single-cell RNA sequencing and 16S rRNA sequencing to determine the impact of microbial dysbiosis and immune activation on glottic scar formation in human patients. This will be complemented by the establishment of a novel murine model to evaluate the role of microbiome-induced immune activation in the development of glottic scarring, as well as the impact of pathogenic bacteria and therapeutic microbiome modulation. The goal is to advance scientific knowledge on the pathophysiology of intubation-related glottic injury and identify potential therapeutic approaches to optimize wound healing and prevent debilitating glottic scarring. The project will be conducted over a 5-year period from May 1, 2025 to April 30, 2030.

Generated 5/13/25, 4:00 AM